The European Journal of Epidemiology is a premier peer-reviewed journal published by Springer, specializing in the vast and critical field of epidemiology. With its ISSN 0393-2990 and E-ISSN 1573-7284, this journal has been a leading platform for disseminating high-quality research since its inception in 1985, encompassing a comprehensive range of topics pertinent to public health and epidemiological science. Proudly based in the Netherlands, the journal has secured a prestigious Q1 ranking in the field of Epidemiology and boasts an impressive Scopus rank of #8 out of 148 in its category, placing it in the 94th percentile among its peers. With a commitment to advancing knowledge and practice in epidemiology, the journal provides invaluable insights for researchers, healthcare professionals, and students, facilitating a better understanding of disease distribution and determinants in populations. While it operates under a subscription model, the European Journal of Epidemiology continues to uphold its reputation as an essential resource for innovative research and public health advancements through the years.

LANCET INFECTIOUS DISEASES is a premier journal published by Elsevier Science Ltd, dedicated to disseminating high-quality research and comprehensive reviews in the field of infectious diseases. Since its inception in 2001, the journal has become a pivotal resource in the medical community, recognized for its rigorous peer-review process and impactful contributions to public health. With an impressive Scopus rank of #2 out of 344 in the category of Medicine - Infectious Diseases, it consistently ranks in the 99th percentile, highlighting its importance and influence in shaping clinical and epidemiological research. The journal's commitment to advancing knowledge in infectious diseases is underscored by its Q1 quartile designation in 2023, affirming its status as a leading academic outlet. Although not an open-access journal, LANCET INFECTIOUS DISEASES provides essential insights for researchers, healthcare professionals, and students, bridging the gap between cutting-edge research and practical application in an increasingly interconnected world.

EPIDEMIOLOGY AND INFECTION is a premier open-access journal published by Cambridge University Press, dedicated to advancing the field of epidemiology and infectious diseases. With an ISSN of 0950-2688 and E-ISSN of 1469-4409, this journal has been at the forefront of disseminating impactful research since its inception in 1970. As of 2023, it holds a prestigious Q2 ranking in both the fields of Epidemiology and Infectious Diseases, reflecting its significant contribution to these critical areas of study, with Scopus rankings placing it at #70 in Epidemiology and #163 in Infectious Diseases. The journal aims to publish high-quality, peer-reviewed studies that contribute to our understanding and management of infectious diseases globally. Operating under an open-access model since 2020, EPIDEMIOLOGY AND INFECTION ensures that research is accessible to a wide audience, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to excellence, this journal is an essential resource for those looking to stay abreast of the latest developments in epidemiological research and infectious disease management.

Open Forum Infectious Diseases (ISSN: 2328-8957; E-ISSN: 2328-8957) is a leading open-access journal published by Oxford University Press, dedicated to advancing the field of infectious diseases. Since its inception in 2014, the journal has provided a platform for researchers to disseminate impactful findings in a rapidly evolving domain, achieving a remarkable Q1 ranking in both the Infectious Diseases and Oncology categories as of 2023. The journal encourages rigorous and innovative research, contributing significantly to global health discussions and informing best practices in clinical settings. As an open-access journal, it ensures that its content is accessible to a wide audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Positioned in the heart of the United States, Open Forum Infectious Diseases serves as a critical resource for the academic community, and its continued commitment to quality and relevance secures its status as an essential publication in the field.

Current Epidemiology Reports, published by Springer Heidelberg, stands as an essential journal in the field of public health and epidemiology. With its ISSN and E-ISSN of 2196-2995, the journal serves as a dynamic platform for disseminating pioneering research and insightful reviews addressing crucial epidemiological trends and challenges. The journal emphasizes open access to enhance the visibility of groundbreaking studies among a global audience, thereby facilitating collaboration and innovation within the scientific community. Although specific metrics such as the impact factor are currently unreported, its commitment to rigorous peer review ensures that only high-quality research is shared. Defined by its aim to report on infectious diseases, chronic health conditions, and emerging epidemiological phenomena, Current Epidemiology Reports is a vital resource for researchers, healthcare professionals, and students eager to stay abreast of advances in this ever-evolving discipline and contribute to the promotion of public health worldwide.

Andes Pediatrica is an esteemed open-access journal published by the SOC CHILENA PEDIATRIA that has been at the forefront of pediatric research since its inception in 2021. Based in Chile, the journal aims to enhance knowledge and dissemination of innovative findings in the fields of pediatrics, perinatology, and child health, making significant contributions to the wellbeing of young populations. With a commitment to open access, it facilitates widespread availability of research, ensuring that crucial information reaches clinicians, researchers, and policymakers globally. Despite its recent launch, Andes Pediatrica has already secured a respectable position within the academic community, reflecting its rank in the Q3 category for 2023 in Pediatrics as per Scopus rankings. By fostering a collaborative environment for sharing cutting-edge research, the journal plays a vital role in addressing contemporary challenges in child health, ultimately striving to improve health outcomes for children both in Chile and beyond.

PLOS Medicine, published by the Public Library of Science, stands as a preeminent open-access journal dedicated to advancing global health through impactful research and discourse. Established in 2004, it has maintained its open-access nature, ensuring that groundbreaking studies in medicine, biochemistry, biotechnology, cell biology, and molecular biology remain accessible to a global audience. With an impressive ranking of 14 out of 636 in General Medicine and a remarkable 97th percentile according to Scopus, PLOS Medicine is recognized for its influential contributions to the medical community. The journal not only aims to disseminate high-quality research but also to foster collaboration across disciplines to improve health outcomes worldwide. Researchers, professionals, and students alike can benefit from the wealth of knowledge and innovations presented in this leading journal, making it an essential resource in the field of medical science.

Preventive Medicine is a premier academic journal published by Academic Press Inc Elsevier Science, renowned for its influential contributions to the fields of Epidemiology and Public Health. Since its inception in 1946 and through its dedicated issues leading into 2024, the journal has established itself as a leading platform for cutting-edge research, boasting impressive Scopus rankings, with a notable Q1 status across relevant categories. This journal provides an essential forum for scholars, practitioners, and policy-makers interested in the prevention of diseases and the promotion of health within populations. With each issue, it disseminates valuable insights on preventive strategies, health behaviors, and epidemiological trends, making it crucial for anyone invested in the advancement of public health sciences. The journal does not offer open access options, ensuring that content remains relevant and targeted to its scholarly audience. Given its valuable contributions and recognition in the academic community, Preventive Medicine continues to play a pivotal role in shaping evidence-based approaches to health promotion and disease prevention in modern societal contexts.

Lancet Regional Health-Western Pacific is a premier academic journal published by Elsevier, focusing on the diverse and dynamic field of health in the Western Pacific region. With an impressive Q1 ranking across several vital categories such as Geriatrics and Gerontology, Health Policy, Infectious Diseases, and Public Health, this journal is positioned at the forefront of health research and policy development. The journal aims to provide a platform for innovative research, reviews, and opinion pieces that lead to improved health outcomes and influence health policy across this geographically and culturally rich area. Offering open access to its content, Lancet Regional Health-Western Pacific ensures that the latest findings are readily available to researchers, professionals, and policymakers alike, ultimately contributing to the global discourse on health issues. As it continually strives to maintain rigorous publication standards, the journal serves as a crucial resource in promoting evidence-based practices and driving advancements in public health.

Ophthalmic Epidemiology, published by Taylor & Francis Inc, stands as a crucial platform in the fields of ophthalmology and epidemiology, with the journal's pivotal contributions recognized in its esteemed category quartiles, ranking Q1 in Ophthalmology and Q2 in Epidemiology for 2023. Since its inception in 1994, the journal has provided a multidisciplinary approach to understanding the distribution and determinants of ocular diseases, thereby informing public health practices and clinical interventions. With a commitment to disseminating high-impact research, it holds a Scopus rank of #45/137 in Ophthalmology and engages a global audience of researchers, practitioners, and students dedicated to advancing the field. Although it is not an open-access journal, Ophthalmic Epidemiology remains a vital resource for innovative studies and reviews that help shape evidence-based strategies to combat vision-related public health issues.